"FDA Approves New Treatment for Diabetes" (Press release)
People who do not match those groups, or who match a contraindication, should not use it without close clinician oversight and in some cases, should not use it at all
We shall also highlight the elevated cost of especially newer GLP-1 Ras, which may pose a significant barrier to equal access of all countries and patients to this medication
However, starting July 1, 2026, the Medicare GLP-1 Bridge provides eligible beneficiaries access to Wegovy for weight loss at a fixed $50 per month outside Part D through December 31, 2027
Consider Telehealth Options If your primary care doctor is unable to prescribe these medications, or if you want a provider who specializes specifically in metabolic health, telehealth platforms are a viable alternative
Menstrual bleeding usually lasts for 3-7 days